RecruitingNCT02328677

ColoCare Study - Colorectal Cancer Cohort

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis


Sponsor

University of Utah

Enrollment

5,000 participants

Start Date

Mar 1, 2007

Study Type

OBSERVATIONAL

Conditions

Summary

ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This trial is following people newly diagnosed with colon or rectal cancer to study how lifestyle, diet, the environment, and biological factors affect cancer survival, recurrence, and quality of life over time. **You may be eligible if...** - You are between 18 and 89 years old (for recent participants, 18–69 years old) - You are male or female - You have been newly diagnosed with colon or rectal cancer (stages I–IV) - You speak English (at most sites) or German (at the University Hospital Heidelberg) - You are mentally and physically able to give consent and participate **You may NOT be eligible if...** - You do not meet the above criteria - You are unwilling to participate in follow-up Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(7)

Cedars-Sinai Medical Center

Los Angeles, California, United States

Lee H. Moffitt Cancer Center

Tampa, Florida, United States

Washington University School of Medicine

St Louis, Missouri, United States

University of Tennessee

Knoxville, Tennessee, United States

Huntsman Cancer Institute

Salt Lake City, Utah, United States

FHCRC

Seattle, Washington, United States

University Hospital Heidelberg

Heidelberg, Baden-Wurttemberg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02328677


Related Trials